In briefBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7550.1110 (Published 11 May 2006) Cite this as: BMJ 2006;332:1110
Inhaled insulin fails to convince watchdog: The German equivalent of England and Wales's National Institute for Health and Clinical Excellence has pointed out the lack of evidence showing that inhaled insulin (Exubera) has advantages over short acting human insulin or insulin analogues administered subcutaneously. There are indications that inhaled insulin can cause severe hypoglycaemia more often than …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial